Literature DB >> 20814940

Isolation and functional use of human NKT cells.

Mark A Exley1, Brian Wilson, Steven P Balk.   

Abstract

This unit details methods for the isolation, in vitro expansion, and functional characterization of human iNKT cells. The term iNKT derives from the fact that a large fraction of murine NKT cells recognize the MHC class I-like CD1d protein, are CD4+ or CD4-CD8- (double negative), and use an identical "invariant" TCRalpha chain, which is generated by precise Valpha14 and Jalpha281 (now renamed Jalpha18) rearrangements with either no N-region diversity or subsequent trimming to nearly identical amino-acid sequence (hence, 'iNKT'). Basic Protocol 1 and Alternate Protocol 1 use multi-color FACS analysis to identify and quantitate rare iNKT cells from human samples. Basic Protocol 2 describes iNKT cell purification. Alternate Protocol 2 describes a method for high-speed FACS sorting of iNKT cells. Alternate Protocol 3 employs a cell sorting approach to isolate iNKT cell clones. A Support Protocol for secondary stimulation and rapid expansion of iNKT cells is also included. Basic Protocol 3 explains functional analysis of iNKT.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20814940     DOI: 10.1002/0471142735.im1411s90

Source DB:  PubMed          Journal:  Curr Protoc Immunol        ISSN: 1934-3671


  9 in total

1.  IAP Antagonists Enhance Cytokine Production from Mouse and Human iNKT Cells.

Authors:  Eleanor Clancy-Thompson; Lestat Ali; Patrick T Bruck; Mark A Exley; Richard S Blumberg; Glenn Dranoff; Michael Dougan; Stephanie K Dougan
Journal:  Cancer Immunol Res       Date:  2017-11-29       Impact factor: 11.151

2.  Ex vivo analysis of resident hepatic pro-inflammatory CD1d-reactive T cells and hepatocyte surface CD1d expression in hepatitis C.

Authors:  K Yanagisawa; S Yue; H J van der Vliet; R Wang; N Alatrakchi; L Golden-Mason; D Schuppan; M J Koziel; H R Rosen; M A Exley
Journal:  J Viral Hepat       Date:  2013-03-11       Impact factor: 3.728

3.  CD4+ invariant natural killer T cells protect from murine GVHD lethality through expansion of donor CD4+CD25+FoxP3+ regulatory T cells.

Authors:  Dominik Schneidawind; Antonio Pierini; Maite Alvarez; Yuqiong Pan; Jeanette Baker; Corina Buechele; Richard H Luong; Everett H Meyer; Robert S Negrin
Journal:  Blood       Date:  2014-10-07       Impact factor: 22.113

4.  Third-party CD4+ invariant natural killer T cells protect from murine GVHD lethality.

Authors:  Dominik Schneidawind; Jeanette Baker; Antonio Pierini; Corina Buechele; Richard H Luong; Everett H Meyer; Robert S Negrin
Journal:  Blood       Date:  2015-03-20       Impact factor: 22.113

5.  Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity.

Authors:  Divya Sekar; Christina Hahn; Bernhard Brüne; Edward Roberts; Andreas Weigert
Journal:  Eur J Immunol       Date:  2012-06       Impact factor: 5.532

6.  CD1d-mediated presentation of endogenous lipid antigens by adipocytes requires microsomal triglyceride transfer protein.

Authors:  Maryam Rakhshandehroo; Sanne M W Gijzel; Rasmus Siersbæk; Marjoleine F Broekema; Colin de Haar; Henk S Schipper; Marianne Boes; Susanne Mandrup; Eric Kalkhoven
Journal:  J Biol Chem       Date:  2014-06-25       Impact factor: 5.157

7.  Natural killer T cells in adipose tissue prevent insulin resistance.

Authors:  Henk S Schipper; Maryam Rakhshandehroo; Stan F J van de Graaf; Koen Venken; Arjen Koppen; Rinke Stienstra; Serge Prop; Jenny Meerding; Nicole Hamers; Gurdyal Besra; Louis Boon; Edward E S Nieuwenhuis; Dirk Elewaut; Berent Prakken; Sander Kersten; Marianne Boes; Eric Kalkhoven
Journal:  J Clin Invest       Date:  2012-08-06       Impact factor: 14.808

8.  Preclinical Evaluation of Invariant Natural Killer T Cells Modified with CD38 or BCMA Chimeric Antigen Receptors for Multiple Myeloma.

Authors:  Renée Poels; Esther Drent; Roeland Lameris; Afroditi Katsarou; Maria Themeli; Hans J van der Vliet; Tanja D de Gruijl; Niels W C J van de Donk; Tuna Mutis
Journal:  Int J Mol Sci       Date:  2021-01-22       Impact factor: 5.923

Review 9.  Recent Advances in Models of Immune-Mediated Drug-Induced Liver Injury.

Authors:  Farah Tasnim; Xiaozhong Huang; Christopher Zhe Wei Lee; Florent Ginhoux; Hanry Yu
Journal:  Front Toxicol       Date:  2021-04-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.